UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Lung Transplantation Outcomes after Crossing Low Level Donor Specific Antibodies without Augmented Immunosuppression

The Journal of heart and lung transplantation, 2021-04, Vol.40 (4), p.S164-S165

2021

Volltextzugriff (PDF)

EBV PCR in the Diagnosis and Monitoring of Posttransplant Lymphoproliferative Disorder: Results of a Two‐Arm Prospective Trial

American journal of transplantation, 2008-05, Vol.8 (5), p.1016-1024

2008

Volltextzugriff (PDF)

Plasma Cytokines and Chemokines in Primary Graft Dysfunction Post-Lung Transplantation

American journal of transplantation, 2009-02, Vol.9 (2), p.389-396

2009

Volltextzugriff (PDF)

Medical complications of lung transplantation

The European respiratory journal, 2004-02, Vol.23 (2), p.334-342

2004

Volltextzugriff (PDF)

Cytochrome P450 3A5 Genotype Is Associated with Early Post-Operative Tacrolimus Serum Levels in Lung Transplant Patients

The Journal of heart and lung transplantation, 2013-04, Vol.32 (4), p.S169-S169

2013

Volltextzugriff (PDF)

704: Donor Glutathione-S-Transferase (GST)-mu Null Genotype Is a Risk Factor for Development of Bronchiolitis Obliterans Syndrome (BOS) and Poor Survival after Lung Transplantation Even after Accounting for Primary Graft Dysfunction (PGD)

The Journal of heart and lung transplantation, 2009-02, Vol.28 (2), p.S310-S310

2009

Volltextzugriff (PDF)

717: Predictors of Time on the Lung Transplant Waiting List after Implementation of the Lung Allocation Score (LAS)

The Journal of heart and lung transplantation, 2009-02, Vol.28 (2), p.S315-S315

2009

Volltextzugriff (PDF)

540 Decreased CMV Infection with Sirolimus Compared to Azathioprine after Lung Transplantation

The Journal of heart and lung transplantation, 2011, Vol.30 (4), p.S181-S182

2011

Volltextzugriff (PDF)

Antiphospholipid Antibodies and Outcomes Following Lung Transplantation

The Journal of heart and lung transplantation, 2022-04, Vol.41 (4), p.S292-S292

2022

Volltextzugriff (PDF)

Change in Panel Reactive Antibodies in Patients Bridged to Lung Transplantation with Extracorporeal Membrane Oxygenation

The Journal of heart and lung transplantation, 2022-04, Vol.41 (4), p.S289-S290

2022

Volltextzugriff (PDF)

97: Impact of Pre-Transplant Recipient Obesity on Outcomes after Lung Transplantation

The Journal of heart and lung transplantation, 2009-02, Vol.28 (2), p.S99-S99

2009

Volltextzugriff (PDF)

700: Plasma Levels of Receptor for Advanced Glycation End-Products (RAGE) Are Associated with Primary Graft Dysfunction

The Journal of heart and lung transplantation, 2009-02, Vol.28 (2), p.S308-S309

2009

Volltextzugriff (PDF)

Treatment of PTLD with Rituximab or Chemotherapy

American journal of transplantation, 2006-03, Vol.6 (3), p.569-576

2006

Volltextzugriff (PDF)

21: Clinical Risk Factors for the Development of Primary Graft Dysfunction

The Journal of heart and lung transplantation, 2008, Vol.27 (2), p.S67-S68

2008

Volltextzugriff (PDF)

57: Validation of the Modification of Diet in Renal Disease (MDRD) Formula in Estimating GFR in Lung Transplant Candidates

The Journal of heart and lung transplantation, 2008, Vol.27 (2), p.S80-S80

2008

Volltextzugriff (PDF)

68: Secondary Pulmonary Hypertension Is a Risk Factor for Primary Graft Dysfunction Following Lung Transplantation for Idiopathic Pulmonary Fibrosis

The Journal of heart and lung transplantation, 2008, Vol.27 (2), p.S84-S84

2008

Volltextzugriff (PDF)

361: The lung allocation score (LAS) and its components predict transplant survival well for groups, but not for individual patients

The Journal of heart and lung transplantation, 2007, Vol.26 (2), p.S189-S190

2007

Volltextzugriff (PDF)

315: Interaction of type of transplant and intraoperative pulmonary artery pressures (PAP) in patients with idiopathic pulmonary fibrosis (IPF) undergoing lung transplantation

The Journal of heart and lung transplantation, 2007, Vol.26 (2), p.S173-S173

2007

Volltextzugriff (PDF)

135: Donor glutathione-s-transferase (GST) mu null genotype in lung transplant recipients is associated with increased rates of bronchiolitis obliterans syndrome (BOS) independent of acute rejection

The Journal of heart and lung transplantation, 2007, Vol.26 (2), p.S108-S108

2007

Volltextzugriff (PDF)

16: Primary graft dysfunction (PGD) and development of bronchiolitis obliterans syndrome (BOS) in lung transplant recipients

The Journal of heart and lung transplantation, 2007, Vol.26 (2), p.S66-S66

2007

Volltextzugriff (PDF)

326: Ethnic differences in diagnoses and outcomes of lung transplant (LTx) recipients – single center experience

The Journal of heart and lung transplantation, 2007, Vol.26 (2), p.S177-S177

2007

Volltextzugriff (PDF)

(203) - Human Leukocyte Antigen Allosensitization in Patients Bridged to Lung Transplantation with Extracorporeal Membrane Oxygenation

The Journal of heart and lung transplantation, 2018-04, Vol.37 (4), p.S89-S89

2018

Volltextzugriff (PDF)

362: Effect of lung allocation score (LAS) on actual post-transplant survival: Early 1-year results

The Journal of heart and lung transplantation, 2007, Vol.26 (2), p.S190-S190

2007

Volltextzugriff (PDF)

Association of Clinical Risk Factors with Functional Status Following Lung Transplantation

American journal of transplantation, 2006-09, Vol.6 (9), p.2191-2201

2006

Volltextzugriff (PDF)

A prospective cross-sectional study of BK virus infection in non-renal solid organ transplant recipients with chronic renal dysfunction

Transplant infectious disease, 2006-06, Vol.8 (2), p.102-107

2006

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)
Japanisch
(2)

Erscheinungsjahr

n.n

Kollektion

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lung Transplantation Outcomes after Crossing Low Level Donor Specific Antibodies without Augmented Immunosuppression

EBV PCR in the Diagnosis and Monitoring of Posttransplant Lymphoproliferative Disorder: Results of a Two‐Arm Prospective Trial

Plasma Cytokines and Chemokines in Primary Graft Dysfunction Post-Lung Transplantation

Medical complications of lung transplantation

Cytochrome P450 3A5 Genotype Is Associated with Early Post-Operative Tacrolimus Serum Levels in Lung Transplant Patients

704: Donor Glutathione-S-Transferase (GST)-mu Null Genotype Is a Risk Factor for Development of Bronchiolitis Obliterans Syndrome (BOS) and Poor Survival after Lung Transplantation Even after Accounting for Primary Graft Dysfunction (PGD)

717: Predictors of Time on the Lung Transplant Waiting List after Implementation of the Lung Allocation Score (LAS)

540 Decreased CMV Infection with Sirolimus Compared to Azathioprine after Lung Transplantation

Antiphospholipid Antibodies and Outcomes Following Lung Transplantation

Change in Panel Reactive Antibodies in Patients Bridged to Lung Transplantation with Extracorporeal Membrane Oxygenation

97: Impact of Pre-Transplant Recipient Obesity on Outcomes after Lung Transplantation

700: Plasma Levels of Receptor for Advanced Glycation End-Products (RAGE) Are Associated with Primary Graft Dysfunction

Treatment of PTLD with Rituximab or Chemotherapy

21: Clinical Risk Factors for the Development of Primary Graft Dysfunction

57: Validation of the Modification of Diet in Renal Disease (MDRD) Formula in Estimating GFR in Lung Transplant Candidates

68: Secondary Pulmonary Hypertension Is a Risk Factor for Primary Graft Dysfunction Following Lung Transplantation for Idiopathic Pulmonary Fibrosis

361: The lung allocation score (LAS) and its components predict transplant survival well for groups, but not for individual patients

315: Interaction of type of transplant and intraoperative pulmonary artery pressures (PAP) in patients with idiopathic pulmonary fibrosis (IPF) undergoing lung transplantation

135: Donor glutathione-s-transferase (GST) mu null genotype in lung transplant recipients is associated with increased rates of bronchiolitis obliterans syndrome (BOS) independent of acute rejection

16: Primary graft dysfunction (PGD) and development of bronchiolitis obliterans syndrome (BOS) in lung transplant recipients

326: Ethnic differences in diagnoses and outcomes of lung transplant (LTx) recipients – single center experience

(203) - Human Leukocyte Antigen Allosensitization in Patients Bridged to Lung Transplantation with Extracorporeal Membrane Oxygenation

362: Effect of lung allocation score (LAS) on actual post-transplant survival: Early 1-year results

Association of Clinical Risk Factors with Functional Status Following Lung Transplantation

A prospective cross-sectional study of BK virus infection in non-renal solid organ transplant recipients with chronic renal dysfunction

Suchergebnisse filtern